Beijing Lu Daopei Hospital, established in 2001 by the esteemed hematologist Professor Lu Daopei, stands as a premier institution specializing in hematology and bone marrow transplantation (BMT) in China. The hospital is renowned for its comprehensive services in diagnosing and treating various blood diseases, including leukemia, lymphoma, and multiple myeloma. ​

Under the visionary leadership of Professor Lu, who is celebrated as a pioneer in hematopoietic stem cell transplants, the hospital has achieved remarkable milestones. Notably, in 1964, Professor Lu performed Asia's first successful syngeneic bone marrow transplant, setting a precedent for hematology treatments in the region

• Hematology: Expertise in diagnosing and treating various blood disorders.​

• Bone Marrow Transplantation: Pioneering procedures for patients with hematologic malignancies.​

• CAR-T Therapy: Advanced immunotherapy treatments for certain types of blood cancers.

• Accreditation: Recognized as a leading private specialist medical group in hematology in China. ​

• Patient Care: Committed to providing personalized and culturally appropriate support throughout the treatment process.​

• Mission: To provide specialized diagnosis and treatment for blood-related diseases, including leukemia, lymphoma, and myeloma, utilizing advanced therapies such as hematopoietic stem cell transplantation and CAR-T therapy

• Vision: To be a global leader in hematology care, combining innovative research with compassionate patient services.

• Second Prize of National Scientific and Technological Progress Award (1985): Awarded to Professor Lu Daopei for advancements in hematology.

• Tan Kah Kee Prize in Medical Sciences (1997): Recognized Professor Lu for his outstanding contributions to medical science.

• Stem Cell and Regenerative Medicine Action Award (2019): The hospital received this award for its leadership in stem cell research and hematology, becoming the first Chinese institution to earn it.